Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia

Leukemia 2026

View at publisher
Authors: Michela Ansuinelli, Nadia Peragine, Maria Stefania De Propris, Maria C. PUZZOLO, Mariangela Di Trani, Loredana Elia, Cristina Skert, Roberto Cairoli, Simona Sica, Alessandro Rambaldi, Alessandra Tucci, Marco Cerrano
+6 more Daniele Vallisa, Valeria Cardinali, Antonino Mulè, Sabina Chiaretti, Anna Guarini, Robin Foà
DOI: 10.1038/s41375-025-02855-5
Cited by: 2
References: 37

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research Chronic Myeloid Leukemia Treatments Lymphoma Diagnosis and Treatment

Publication details

Journal / source
Leukemia
Publisher
Springer Science and Business Media LLC
Volume
40
Issue
3
Pages
577–586
Publication date
22 January 2026
Language
EN